See the original post here:
Arvinas Gives Back to Local Greater New Haven Community

Read more here:
IN8bio Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Corporate Update

Read more here:
Lisata Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Originally posted here:
Sutro Biopharma Reports Full Year 2022 Financial Results, Business Highlights and Select Anticipated Milestones

Here is the original post:
Surrozen Provides Fourth Quarter and Full Year 2022 Financial Results and Update on Clinical Pipeline and Corporate Progress

See the article here:
Biogen Provides Update on FDA Advisory Committee Meeting on Tofersen for SOD1-ALS

Read the original:
Agile Therapeutics Reports Fourth Quarter & Full Year 2022 Financial Results and Provides Corporate Update

Read more here:
Burning Rock provides an update on 2022 revenue guidance

See original here:
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

Go here to see the original:
VYNE Therapeutics Announces First Vitiligo Patient Dosed in Phase 1a/b Clinical Trial of Novel BET Inhibitor VYN201

Read this article:
Nkarta Promotes David R. Shook, M.D., to Chief Medical Officer

See original here:
Syneos Health Announces Chief Financial Officer Transition

Read the rest here:
atai Life Sciences Announces Results from the Kures Therapeutics Phase 1 Trial of KUR-101

View original post here:
Applied Molecular Transport Announces Top-line Phase 2 Results from LOMBARD Monotherapy Trial of Oral AMT-101 in Patients with Moderate-to-Severe...

See the original post here:
Orion Corporation completed share acquisitions

See more here:
Enzo Biochem, Inc. to Report First Quarter Fiscal 2023 Financial Results and Business Update on Monday, December 12th

Go here to read the rest:
Aptose to Hold Clinical Update and Data Review of AML Drug Tuspetinib on Sunday, December 11th

Visit link:
Orion Research Foundation is awarding EUR 1 million in grants and two EUR 100,000 special grants today

Here is the original post:
Rain Therapeutics Announces a Poster Presentation at the 34th EORTC/AACR/NCI Symposium

See more here:
Morphic Presents New Positive MORF-057 Phase 1 Data at UEG Week 2022